Form 10-Q
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D. C. 20549

 

 

FORM 10-Q

 

 

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For Quarterly Period Ended March 31, 2009

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For Transition Period from              to             .

Commission File Number 1-12658

 

 

ALBEMARLE CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

VIRGINIA   54-1692118

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

451 FLORIDA STREET

BATON ROUGE, LOUISIANA

  70801
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code - (225) 388-8011

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  ¨    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer   x      Accelerated filer   ¨

 

Non-accelerated filer

 

 

¨

 

 

(Do not check if a smaller reporting company)

  

 

Smaller reporting company

 

 

¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

Number of shares of common stock, $.01 par value, outstanding as of May 1, 2009: 91,446,242

 

 

 


Table of Contents

ALBEMARLE CORPORATION

INDEX – FORM 10-Q

 

    Page
Number(s)

PART I. FINANCIAL INFORMATION

 
    Item 1.   Financial Statements (Unaudited)  
  Consolidated Statements of Income – Three Months Ended March 31, 2009 and 2008   3
  Condensed Consolidated Balance Sheets – March 31, 2009 and December 31, 2008   4
  Condensed Consolidated Statements of Cash Flows – Three Months Ended March 31, 2009 and 2008   5
  Condensed Consolidated Statements of Comprehensive (Loss) Income – Three Months Ended March 31, 2009 and 2008   6
  Notes to the Condensed Consolidated Financial Statements   7-12
    Item 2.   Management’s Discussion and Analysis of Financial Condition and Results of Operations   13-23
    Item 3.   Quantitative and Qualitative Disclosures about Market Risk   23
    Item 4.   Controls and Procedures   24

PART II. OTHER INFORMATION

 
    Item 1.   Legal Proceedings   24
    Item 1A.   Risk Factors   24
    Item 2.   Unregistered Sales of Equity Securities and Use of Proceeds   25
    Item 6.   Exhibits   25

SIGNATURES

  26

EXHIBITS

 

 

2


Table of Contents

PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements (Unaudited).

ALBEMARLE CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME

(In Thousands, Except Per Share Amounts)

(Unaudited)

 

     Three Months Ended
March 31,
 
     2009     2008  

Net sales

   $ 486,591     $ 668,177  

Cost of goods sold

     396,085       500,766  
                

Gross profit

     90,506       167,411  

Selling, general and administrative expenses

     45,434       63,519  

Research and development expenses

     16,145       16,800  

Restructuring charges

     —         3,278  
                

Operating profit

     28,927       83,814  

Interest and financing expenses

     (6,274 )     (10,216 )

Other (expenses) income, net

     (1,131 )     2,846  
                

Income before income tax expense and equity in net income of unconsolidated investments

     21,522       76,444  

Income tax expense

     525       16,626  
                

Income before equity in net income of unconsolidated investments

     20,997       59,818  

Equity in net income of unconsolidated investments (net of tax)

     5,949       7,028  
                

Net income

     26,946       66,846  

Net income attributable to noncontrolling interests

     (1,547 )     (3,585 )
                

Net income attributable to Albemarle Corporation

   $ 25,399     $ 63,261  
                

Basic earnings per share

   $ 0.28     $ 0.68  
                

Diluted earnings per share

   $ 0.28     $ 0.67  
                

Cash dividends declared per share of common stock

   $ 0.125     $ 0.12  

Weighted-average common shares outstanding - basic

     91,380       92,654  

Weighted-average common shares outstanding - diluted

     91,797       93,905  

See accompanying Notes to the Condensed Consolidated Financial Statements.

 

3


Table of Contents

ALBEMARLE CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In Thousands)

 

     March 31,
2009
    December 31,
2008
 
     (Unaudited)  

ASSETS

    

Current assets:

    

Cash and cash equivalents

   $ 183,899     $ 253,303  

Trade accounts receivable, less allowance for doubtful accounts (2009 - $1,889; 2008 - $1,899)

     279,417       280,601  

Other accounts receivable

     34,413       47,157  

Inventories

     440,211       538,857  

Other current assets

     63,639       59,005  
                

Total current assets

     1,001,579       1,178,923  
                

Property, plant and equipment, at cost

     2,318,778       2,322,996  

Less accumulated depreciation and amortization

     1,313,654       1,310,648  
                

Net property, plant and equipment

     1,005,124       1,012,348  

Investments

     122,329       121,951  

Other assets

     133,196       113,717  

Goodwill

     263,912       278,767  

Other intangibles, net of amortization

     158,949       167,011  
                

Total assets

   $ 2,685,089     $ 2,872,717  
                

LIABILITIES AND EQUITY

    

Current liabilities:

    

Accounts payable

   $ 158,292     $ 224,333  

Accrued expenses

     118,476       170,512  

Current portion of long-term debt

     26,256       26,202  

Dividends payable

     10,139       9,675  

Income taxes payable

     9,733       7,645  
                

Total current liabilities

     322,896       438,367  
                

Long-term debt

     891,878       906,062  

Postretirement benefits

     47,700       47,803  

Pension benefits

     146,114       146,381  

Other noncurrent liabilities

     137,784       142,783  

Deferred income taxes

     73,073       74,838  

Commitments and contingencies (Note 12)

    

Equity:

    

Albemarle Corporation shareholders’ equity:

    

Common stock, $.01 par value, issued and outstanding – 91,397 in 2009 and 90,980 in 2008

     914       910  

Accumulated other comprehensive loss

     (156,881 )     (100,642 )

Retained earnings

     1,169,352       1,165,503  
                

Total Albemarle Corporation shareholders’ equity

     1,013,385       1,065,771  

Noncontrolling interests

     52,259       50,712  
                

Total equity

     1,065,644       1,116,483  
                

Total liabilities and equity

   $ 2,685,089     $ 2,872,717  
                

See accompanying Notes to the Condensed Consolidated Financial Statements.

 

4


Table of Contents

ALBEMARLE CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In Thousands)

(Unaudited)

 

     Three Months Ended
March 31,
 
     2009     2008  

Cash and cash equivalents at beginning of year

   $ 253,303     $ 130,551  
                

Cash flows from operating activities:

    

Net income

     26,946       66,846  

Adjustments to reconcile net income to cash flows from operating activities:

    

Depreciation and amortization

     25,775       26,542  

Stock-based compensation

     (6,409 )     4,590  

Excess tax benefits realized from stock-based compensation arrangements

     (226 )     (6,920 )

Equity in net income of unconsolidated investments

     (5,949 )     (7,028 )

Restructuring charges

     —         3,278  

Working capital changes

     (32,777 )     (63,541 )

Dividends received from unconsolidated investments and nonmarketable securities

     3,961       1,295  

Pension and postretirement expense

     2,396       394  

Pension and postretirement contributions

     (2,544 )     (2,894 )

Unrealized loss on investments in marketable securities

     942       827  

Net change in noncurrent income tax payables and receivables

     (2,364 )     376  

Net change in noncurrent environmental liabilities

     (3,051 )     413  

Withholding taxes paid on stock-based compensation award distributions

     (4,577 )     (10,156 )

Deferred income taxes

     (4,190 )     10,767  

Other, net

     (2,032 )     (5,984 )
                

Net cash (used in) provided from operating activities

     (4,099 )     18,805  
                

Cash flows from investing activities:

    

Capital expenditures

     (33,068 )     (20,139 )

Cash transferred and payments related to the Thann facility divestiture

     —         (2,556 )

Cash payments related to the Port de Bouc facility divestiture

     (4,349 )     —    

Collection of note receivable from sale of land

     —         6,000  

Investments in marketable securities

     (299 )     (3,065 )
                

Net cash used in investing activities

     (37,716 )     (19,760 )
                

Cash flows from financing activities:

    

Repayments of long-term debt

     (35,834 )     (45,273 )

Proceeds from borrowings

     22,140       199,928  

Dividends paid to shareholders

     (10,961 )     (9,707 )

Purchases of common stock

     —         (151,137 )

Proceeds from exercise of stock options

     663       3,398  

Excess tax benefits realized from stock-based compensation arrangements

     226       6,920  

Dividends paid to noncontrolling interests

     (2,911 )     (5,486 )

Other

     —         (107 )
                

Net cash used in financing activities

     (26,677 )     (1,464 )
                

Net effect of foreign exchange on cash and cash equivalents

     (912 )     6,998  
                

(Decrease) increase in cash and cash equivalents

     (69,404 )     4,579  
                

Cash and cash equivalents at end of period

   $ 183,899     $ 135,130  
                

See accompanying Notes to the Condensed Consolidated Financial Statements.

 

5


Table of Contents

ALBEMARLE CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME

(In Thousands)

(Unaudited)

 

     Three Months Ended
March 31,
 
     2009     2008  

Net income

   $ 26,946     $ 66,846  

Other comprehensive (loss) income, net of tax:

    

Unrealized gain on marketable securities

     1       —    

Amortization of realized loss on treasury lock agreements

     37       35  

Changes in net loss and prior service cost

     (3,190 )     (463 )

Foreign currency translation

     (53,087 )     65,525  
                

Total other comprehensive (loss) income, net of tax

     (56,239 )     65,097  
                

Comprehensive (loss) income

     (29,293 )     131,943  
                

Comprehensive income attributable to noncontrolling interests

     (1,547 )     (3,585 )
                

Comprehensive (loss) income attributable to Albemarle Corporation

   $ (30,840 )   $ 128,358  
                

See accompanying Notes to the Condensed Consolidated Financial Statements.

 

6


Table of Contents

ALBEMARLE CORPORATION AND SUBSIDIARIES

Notes to the Condensed Consolidated Financial Statements

1. In the opinion of management, the accompanying condensed consolidated financial statements of Albemarle Corporation and our wholly owned, majority owned and controlled subsidiaries (collectively, “Albemarle,” “we,” “us,” “our,” or “the Company”) contain all adjustments necessary for a fair presentation, in all material respects, of our condensed consolidated financial position as of March 31, 2009 and December 31, 2008, and our condensed consolidated results of operations, comprehensive (loss) income and cash flows for the three-month periods ended March 31, 2009 and 2008. All adjustments are of a normal and recurring nature. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2008, which was filed with the Securities and Exchange Commission, or the SEC, on February 27, 2009. The December 31, 2008 consolidated balance sheet data herein was derived from audited financial statements, but does not include all disclosures required by generally accepted accounting principles in the United States, or the U.S. The results of operations for the three-month period ended March 31, 2009 are not necessarily indicative of the results to be expected for the full year. Certain reclassifications have been made to the accompanying consolidated financial statements and the notes thereto to conform to the current presentation.

2. On January 1, 2009, we adopted Financial Accounting Standards Board, or FASB, Statement of Financial Accounting Standards, or SFAS, No. 160, “Noncontrolling Interests in Consolidated Financial Statements—an amendment of ARB No. 51.” This standard changed the accounting for and reporting of minority interests (now referred to as noncontrolling interests). Noncontrolling interests are now classified as equity in our consolidated financial statements. SFAS No. 160 also changed the consolidated statement of income presentation format by requiring net income to include the net income for both the parent and the noncontrolling interests, with disclosure of both amounts on the consolidated statement of income. The calculation of earnings per share continues to be based on net income amounts attributable to the parent. As a result of the adoption of SFAS No. 160, prior period amounts related to noncontrolling interests have been reclassified to conform to the current period presentation.

3. The three-month period ended March 31, 2008 includes charges amounting to $3.3 million ($2.1 million after income taxes, or $0.02 per share) that relate to severance in conjunction with personnel reductions at the Company’s former Richmond, Virginia headquarters and Singapore sales office.

4. Our consolidated statements of income include the following foreign exchange transaction (losses) gains for the three-month periods ended March 31, 2009 and 2008:

 

     Three Months Ended
March 31,
     2009     2008
     (In thousands)

Cost of goods sold

   $ (967 )   $ 3,623

Other (expenses) income, net

     (1,674 )     1,330
              

Total foreign exchange transaction (losses) gains

   $ (2,641 )   $ 4,953
              

 

7


Table of Contents

5. Our effective tax rate fluctuates based on, among other factors, where income is earned and the level of income relative to available tax credits. The significant differences between the U.S. federal statutory income tax rate on pretax income and the effective income tax rate for the three-month periods ended March 31, 2009 and 2008 are as follows:

 

     % of Income Before Income Taxes  
     Three Months Ended
March 31,
 
     2009     2008  

Federal statutory rate

   35.0 %   35.0 %

State taxes, net of federal tax benefit

   0.2     0.5  

Impact of foreign operations, net

   (19.4 )   (13.1 )

Increase in valuation allowance

   0.2     —    

Depletion

   (1.7 )   (1.2 )

Effect of net income attributable to noncontrolling interests

   (0.1 )   (0.5 )

Revaluation of unrecognized tax benefits/reserve requirements

   0.6     1.0  

Other items, net

   (0.8 )   0.1  
            

Effective income tax rate excluding non-recurring items

   14.0 %   21.8 %

Non-recurring items

   (11.6 )   —    
            

Effective income tax rate

   2.4 %   21.8 %
            

During the three-month period ended March 31, 2009, we recorded various non-recurring items totaling a net $2.5 million benefit, resulting from adjustments related to prior periods. Of this net benefit, the significant items were a $1.2 million increase in a valuation allowance for losses at our Brazilian entity and a net benefit of $2.7 million related to unrecognized tax benefits.

We are subject to income taxes in the U.S. and numerous foreign jurisdictions. We are no longer subject to U.S. federal income tax examinations by tax authorities for years before 2005. The Internal Revenue Service, or IRS, has completed a review of our income tax returns through year 2004. During 2008, we received examination notifications from the IRS on tax years 2005 through 2007. We anticipate tax resolutions related to these years in either 2009 or 2010.

With respect to jurisdictions outside the U.S., we are no longer subject to income tax audits for years before 2002. Subsequent to March 31, 2009, the tax examination of our subsidiaries in Germany for the years 2002 through 2005 was completed.

While we believe we have adequately provided for all tax positions, amounts asserted by taxing authorities could be greater than our accrued position. Accordingly, additional provisions on federal and foreign tax-related matters could be recorded in the future as revised estimates are made or the underlying matters are settled or otherwise resolved.

Since the timing of resolutions and/or closure of tax audits is uncertain, it is difficult to predict with certainty the range of reasonably possible significant increases or decreases in the liability for unrecognized tax benefits that may occur within the next twelve months. Our current view is that it is reasonably possible that we could record a decrease in the liability for unrecognized tax benefits, relating to a number of issues, up to approximately $31 million as a result of settlements with taxing authorities and closure of tax statutes.

6. On January 1, 2009, we adopted FASB Staff Position No. EITF 03-6-1, “Determining Whether Instruments Granted in Share-Based Payment Transactions Are Participating Securities,” or FSP EITF 03-6-1. FSP EITF 03-6-1 states that unvested share-based payment awards that contain nonforfeitable rights to dividends, such as certain of our restricted stock awards, are participating securities and therefore shall be included in the earnings per share calculation pursuant to the two class method described in SFAS No. 128, “Earnings Per Share.” FSP EITF 03-6-1 requires all prior-period earnings per share data to be adjusted retrospectively, and as a result, all prior period earnings per share data presented herein have been adjusted to conform to these provisions. For the three-month period ended March 31, 2008, basic and diluted earnings per share each decreased $0.01 as a result of an increase in our basic and diluted weighted-average common shares outstanding of approximately 305,000 and 217,000 shares, respectively. Adoption of FSP EITF 03-6-1 did not impact our reported basic or diluted earnings per share for the three-month period ended March 31, 2009; however, our basic and diluted weighted-average common shares outstanding increased by approximately 343,000 and 201,000 shares, respectively.

 

8


Table of Contents

Basic and diluted earnings per share for the three-month periods ended March 31, 2009 and 2008 are calculated as follows:

 

     Three Months Ended
March 31,
     2009    2008
     (In thousands, except per share amounts)

Basic earnings per share

     

Numerator:

     

Net income attributable to Albemarle Corporation

   $ 25,399    $ 63,261
             

Denominator:

     

Weighted-average common shares for basic earnings per share

     91,380      92,654
             

Basic earnings per share

   $ 0.28    $ 0.68
             

Diluted earnings per share

     

Numerator:

     

Net income attributable to Albemarle Corporation

   $ 25,399    $ 63,261
             

Denominator:

     

Weighted-average common shares for basic earnings per share

     91,380      92,654

Incremental shares under stock compensation plans

     417      1,251
             

Total shares

     91,797      93,905
             

Diluted earnings per share

   $ 0.28    $ 0.67
             

7. Cash dividends declared for the three-month period ended March 31, 2009 totaled 12.5 cents per share and were paid on April 1, 2009. Cash dividends declared for the three-month period ended March 31, 2008 totaled 12.0 cents per share and were paid on April 1, 2008.

8. The following table provides a breakdown of inventories at March 31, 2009 and December 31, 2008:

 

     March 31,
2009
   December 31,
2008
     (In thousands)

Finished goods

   $ 303,897    $ 395,919

Raw materials

     88,844      95,617

Stores, supplies and other

     47,470      47,321
             

Total inventories

   $ 440,211    $ 538,857
             

9. Long-term debt at March 31, 2009 and December 31, 2008 consists of the following:

 

     March 31,
2009
   December 31,
2008
     (In thousands)

Variable-rate domestic bank loans

   $ 495,000    $ 522,835

Senior notes

     324,805      324,796

Fixed rate foreign borrowings

     46,200      47,640

Variable-rate foreign bank loans

     38,891      23,320

Capital lease obligation

     12,604      12,975

Miscellaneous

     634      698
             

Total

     918,134      932,264

Less amounts due within one year

     26,256      26,202
             

Total long-term debt

   $ 891,878    $ 906,062
             

Maturities of long-term debt are as follows: 2009—$24.0 million; 2010—$13.2 million; 2011—$9.0 million; 2012—$7.4 million; 2013—$504.8 million and 2014 through 2017—$359.7 million.

 

9


Table of Contents

10. The Company has the following recorded environmental liabilities primarily included in “Other noncurrent liabilities” at March 31, 2009 (in thousands):

 

Beginning balance at December 31, 2008

   $  18,970  

Changes in estimates

     (2,374 )

Payments

     (150 )

Foreign exchange

     (887 )
        

Ending balance at March 31, 2009

   $ 15,559  
        

The amounts recorded represent our future remediation and other anticipated environmental liabilities. Although it is difficult to quantify the potential financial impact of compliance with environmental protection laws, management estimates (based on the latest available information) that there is a reasonable possibility that future environmental remediation costs associated with our past operations, in excess of amounts already recorded, could be up to approximately $17 million before income taxes.

We believe that any sum we may be required to pay in connection with environmental remediation matters in excess of the amounts recorded should occur over a period of time and should not have a material adverse effect upon our results of operations, financial condition or cash flows on a consolidated annual basis, although any such sum could have a material adverse impact on our results of operations, financial condition or cash flows in a particular quarterly reporting period.

On July 3, 2006, we received a Notice of Violation, or NOV, from the U.S. Environmental Protection Agency Region 4, or EPA, regarding the implementation of the Pharmaceutical Maximum Achievable Control Technology standards at our plant in Orangeburg, SC. The alleged violations include (i) the applicability of the specific regulations to certain intermediates manufactured at the plant, (ii) failure to comply with certain reporting requirements, (iii) improper evaluation and testing to properly implement the regulations and (iv) the sufficiency of the leak detection and repair program at the plant. We are currently engaged in discussions with the EPA seeking to resolve these allegations, but no assurances can be given that we will be able to reach a resolution that is acceptable to both parties. Any settlement or finding adverse to us could result in the payment by us of fines, penalties, capital expenditures, or some combination thereof. At this time, it is not possible to predict with any certainty the outcome of our discussions with the EPA or the financial impact which may result therefrom. However, we do not expect any financial impact to have a material adverse effect on the results of operations or the financial position of the Company.

11. Segment income represents operating profit (adjusted for significant non-recurring items) and equity in net income of unconsolidated investments and is reduced by net income attributable to noncontrolling interests. Segment data includes intersegment transfers of raw materials at cost, foreign exchange transaction gains and losses and allocations for certain corporate costs.

Summarized financial information concerning our reportable segments is shown in the following table. Corporate & other includes corporate-related items not allocated to the reportable segments.

 

     Three Months Ended
March 31,
     2009     2008
     (In thousands)

Net sales:

    

Polymer Additives

   $ 123,200     $ 244,590

Catalysts

     242,587       276,097

Fine Chemicals

     120,804       147,490
              

Total net sales

   $ 486,591     $ 668,177
              

Segment operating profit (loss):

    

Polymer Additives

   $ (11,563 )   $ 30,269

Catalysts

     29,761       46,156

Fine Chemicals

     10,283       23,480
              

Subtotal

   $ 28,481     $ 99,905
              

 

10


Table of Contents
     Three Months Ended
March 31,
 
     2009     2008  
     (In thousands)  

Equity in net income (loss) of unconsolidated investments:

    

Polymer Additives

   $ 48     $ 1,472  

Catalysts

     5,928       5,566  

Fine Chemicals

     —         —    

Corporate & other

     (27 )     (10 )
                

Total equity in net income of unconsolidated investments

   $ 5,949     $ 7,028  
                

Net (income) loss attributable to noncontrolling interests:

    

Polymer Additives

   $ (215 )   $ (1,989 )

Catalysts

     —         —    

Fine Chemicals

     (1,553 )     (1,935 )

Corporate & other

     221       339  
                

Total net income attributable to noncontrolling interests

   $ (1,547 )   $ (3,585 )
                

Segment income (loss):

    

Polymer Additives

   $ (11,730 )   $ 29,752  

Catalysts

     35,689       51,722  

Fine Chemicals

     8,730       21,545  
                

Total segment income

     32,689       103,019  

Corporate & other (1)

     640       (12,484 )

Restructuring charges

     —         (3,278 )

Interest and financing expenses

     (6,274 )     (10,216 )

Other (expenses) income, net

     (1,131 )     2,846  

Income tax expense

     (525 )     (16,626 )
                

Net income attributable to Albemarle Corporation

   $ 25,399     $ 63,261  
                

 

(1)

Corporate and other charges for the three-month period ended March 31, 2009 included $7.8 million in adjustments associated with the reversal of certain long-term employee benefit accruals. This adjustment is primarily included in “Selling, general and administrative expenses” in our consolidated statements of income.

12. Commitments and Contingencies

We have contracts with certain of our customers, which serve as guarantees on product delivery and performance according to customer specifications that can cover both shipments on an individual basis as well as blanket coverage of multiple shipments under customer supply contracts, that are executed through certain financial institutions. The financial coverage provided by these guarantees is typically based on a percentage of net sales value.

In connection with the remediation of a local landfill site as required by the German environmental authorities, we have pledged certain of our land and housing facilities at our Bergheim, Germany plant site with a recorded value of $5.9 million.

In addition, we are involved from time to time in legal proceedings of types regarded as common in our businesses, particularly administrative or judicial proceedings seeking remediation under environmental laws, such as Superfund, products liability and premises liability litigation. We maintain a financial accrual for these proceedings that includes defense costs and potential damages, as estimated by our general counsel. We also maintain insurance to mitigate certain of these risks. See Note 10 above.

 

11


Table of Contents

13. The following information is provided for domestic and foreign pension and postretirement benefit plans:

 

     Three Months Ended
March 31,
 
     2009     2008  
     (In thousands)  

Net Periodic Pension Benefit Cost (Credit):

    

Service cost

   $ 2,842     $ 2,867  

Interest cost

     8,060       7,934  

Expected return of assets

     (10,626 )     (10,562 )

Net transition asset

     (3 )     (2 )

Prior service benefit

     (247 )     (256 )

Net loss

     3,106       1,857  
                

Total net periodic pension benefit cost

   $ 3,132     $ 1,838  
                

We have made $1.5 million in contributions to our qualified and nonqualified pension plans during the three-month period ended March 31, 2009.

 

     Three Months Ended
March 31,
 
     2009     2008  
     (In thousands)  

Net Periodic Postretirement Benefit Cost (Credit):

    

Service cost

   $ 93     $ 121  

Interest cost

     947       863  

Expected return of assets

     (144 )     (143 )

Prior service benefit

     (1,893 )     (2,399 )

Net loss

     261       114  
                

Total net periodic postretirement benefit (credit)

   $ (736 )   $ (1,444 )
                

We paid approximately $1.0 million in premiums to the U.S. postretirement benefit plan during the three-month period ended March 31, 2009.

14. The Company has the following recorded workforce reduction liabilities included in “Accrued expenses” at March 31, 2009 (in thousands):

 

Beginning balance at December 31, 2008

   $ 20,276  

Payments

     (12,431 )

Amounts reversed to income

     (227 )

Foreign exchange

     (180 )
        

Ending balance at March 31, 2009

   $ 7,438  
        

During the three-month period ended March 31, 2009, we made payments as a result of restructuring charges recorded during the year ended December 31, 2008. The majority of the payments under this restructuring plan are expected to occur in 2009.

15. Recently Issued Accounting Pronouncements

In December 2008, FASB issued FASB Staff Position No. FAS 132(R)-1, “Employers’ Disclosures about Postretirement Benefit Plan Assets,” or FSP No. FAS 132(R)-1. FSP No. FAS 132(R)-1 applies to employers subject to SFAS No. 132(R) and is effective for fiscal years ending after December 15, 2009. FSP No. FAS 132(R)-1 requires additional disclosures regarding benefit plan assets including (a) the investment allocation decision process, (b) the fair value of each major category of plan assets and (c) the inputs and valuation techniques used to measure the fair value of plan assets. We are currently evaluating the additional disclosures required upon adoption of FSP No. FAS 132(R)-1.

In April 2009, the FASB issued Staff Position No. FAS 107-1 and APB 28-1, “Interim Disclosures about Fair Value of Financial Instruments,” requiring companies to provide additional fair value information for certain financial instruments in interim financial statements, similar to what is currently required to be disclosed on an annual basis. We will adopt this standard beginning in the interim period ended June 30, 2009.

 

12


Table of Contents
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

The following is a discussion and analysis of our financial condition and results of operations since December 31, 2008. A discussion of consolidated financial condition and sources of additional capital is included under a separate heading “Financial Condition and Liquidity” on page 20.

Forward-looking Statements

Some of the information presented in this Quarterly Report on Form 10-Q, including the documents incorporated by reference, may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on our current expectations, which are in turn based on assumptions that we believe are reasonable based on our current knowledge of our business and operations. We have used words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “should,” “will” and variations of such words and similar expressions to identify such forward-looking statements.

These forward-looking statements are not guarantees of future performance and involve certain risks, uncertainties and assumptions, which are difficult to predict and many of which are beyond our control. There can be no assurance, therefore, that our actual results will not differ materially from the results and expectations expressed or implied in the forward-looking statements. Factors that could cause actual results to differ materially include, without limitation:

 

   

deterioration in economic and business conditions;

 

   

future financial and operating performance of our major customers and industries served by us;

 

   

the timing of orders received from customers;

 

   

the gain or loss of significant customers;

 

   

competition from other manufacturers;

 

   

changes in the demand for our products;

 

   

limitations or prohibitions on the manufacture and sale of our products;

 

   

availability of raw materials;

 

   

changes in the cost of raw materials and energy, and our inability to pass through such increases;

 

   

performance of acquired companies;

 

   

changes in our markets in general;

 

   

fluctuations in foreign currencies;

 

   

changes in laws and increased government regulation of our operations or our products;

 

   

the occurrence of claims or litigation;

 

   

the occurrence of natural disasters;

 

   

the inability to maintain current levels of product or premises liability insurance or the denial of such coverage;

 

   

political unrest affecting the global economy, including adverse effects from terrorism or hostilities;

 

   

changes in accounting standards;

 

   

the inability to achieve results from our global manufacturing cost reduction initiatives as well as our ongoing continuous improvement and rationalization programs;

 

   

changes in interest rates, to the extent such rates (1) affect our ability to raise capital or increase our cost of funds, (2) have an impact on the overall performance of our pension fund investments and (3) increase our pension expense and funding obligations;

 

   

volatility and substantial uncertainties in the debt and equity markets; and

 

13


Table of Contents
   

the other factors detailed from time to time in the reports we file with the SEC.

We assume no obligation to provide revisions to any forward-looking statements should circumstances change, except as otherwise required by securities and other applicable laws. The following discussion should be read together with our consolidated financial statements and related notes included in this Quarterly Report on Form 10-Q.

Overview

We are a leading global developer, manufacturer and marketer of highly-engineered specialty chemicals. Our products and services enhance the value of our customers’ end-products by improving performance, providing essential product attributes, lowering cost and simplifying processing. We sell a highly diversified mix of products to a wide range of customers, including petroleum refiners, utilities providers, and manufacturers of consumer electronics, building and construction materials, automotive parts, packaging, pharmachemicals and agrichemicals. We believe that our commercial and geographic diversity, technical expertise, flexible, low-cost global manufacturing base, and experienced management team enable us to maintain leading market positions in those areas of the specialty chemicals industry in which we operate.

First Quarter 2009

During the first quarter of 2009:

 

   

quarterly net sales of $486.6 million resulted in earnings (net income attributable to Albemarle Corporation) of $25.4 million, or $0.28 per share

 

   

solid progress on cost reduction initiatives

 

   

inventory levels reduced by $98.6 million

 

   

quarterly dividend increased to $0.125 per share of common stock ($0.50 annually)

Outlook

We continue to expect 2009 to be a very challenging year. While there is still much uncertainty as to the length of the current global economic downturn and to when meaningful demand will be restored in consumer end-markets, we believe our proactive response to the weakened global economic conditions should position our Company to operate leaner, more efficiently and on a lower cost basis while preserving growth opportunities.

Polymer Additives: We expect the continued downturn in the consumer electronics, automotive and construction sectors to impact volumes and profitability of our Polymer Additives segment. Although we are taking steps to restructure our operations and cut costs, we expect challenges in this business to continue until demand returns and our production rates improve. In the longer term, the increasing standard of living around the globe should drive higher demand for electrical and electronic equipment and new construction, and the potential for increasingly stringent fire-safety regulations and global climate initiatives should increase the need for insulation materials.

We are continuing to increase our presence in China as we build a foundation for expanding our business in Asia. Expansion of our now wholly owned antioxidants facility in Shanghai is expected to come on-line in early 2010.

New product development momentum continues in our Polymer Additives segment. The trend in some electronic components toward halogen-free flame retardants, while challenging our legacy products, also creates numerous development opportunities with our diverse customer base. We plan to begin commercializing sales of a new halogen-free product in one of our key-growth markets and have several others in various stages of development. We also plan to commercialize a new polyurea curative, which offers greater cure speed flexibility and thus expands and increases performance and use.

Catalysts: We expect revenue growth in our Catalysts segment to be driven by global demand for petroleum products, generally deteriorating quality of crude oil feedstock and implementation of more stringent fuel quality requirements as a part of clean air initiatives. While we continue to monitor developments in the global economy, we expect our Catalysts segment profit growth in 2009 to come primarily from new product introductions, new markets that we penetrate, FCC pricing improvements, and the continued growth in our polyolefin catalysts business.

With continuing global demand for oil and consumer fuel and tightening fuel quality regulations, we believe refiners will process more sour crudes, which should require additional HPC catalysts to remove the metals and impurities, further driving demand for these catalysts. We must also continue to successfully pass through metals costs and ensure optimal inventory levels in periods of declining metals prices.

 

14


Table of Contents

Our focus in FCC catalysts is on improving margins to support the value these products bring to the market. While we believe there remains room for further margin improvement, in order to be successful we must continue to deliver high-performing, superior quality products to meet the growing demands of refiners processing increasingly heavy crudes. We have seen incremental margin increases, although we continue to face raw material cost pressures related to imported rare earths and transportation costs. We believe, however, that our price increases should offset increasing raw material costs, but there is no guarantee that will occur.

We are focused on new product development in catalysts and have introduced high-throughput experimentation to more rapidly test and develop new technologies. Our marketing and research groups are tightly aligned so we can continue to bring innovative technologies to the market. We will continue to explore new opportunities for our catalysts in the alternative fuels business, which includes biodiesel, Canadian oil sands, gas to liquids (GTL), and coal to liquids (CTL) markets. These opportunities become increasingly viable with sustained price increases.

Fine Chemicals: In our performance chemicals sector, the current poor economic climate is impacting our bromine franchise in oil completion fluids and bromine consumption. We expect continued negative impacts from low production rates. Our fine chemistry services business continues to benefit from the continued rapid pace of innovation and the introduction of new products, coupled with the movement by pharmaceutical companies to outsource certain research, product development and manufacturing functions. Our long-term strategic areas of focus in our Fine Chemicals segment are to maximize our bromine franchise value in the performance chemicals sector and to continue the growth of our fine chemistry services business.

We are focused on profitably growing our globally competitive bromine and derivatives production network to serve all major bromine consuming products and markets. As we supply bromine feed stocks to our Polymer Additives segment, our profitability is generally impacted as market conditions change in that sector. In fine chemistry services, our new products pipeline continues to be robust, allowing us to develop preferred outsourcing positions serving leading chemical and pharmaceutical companies in diverse industries. We remain confident in continuing to generate growth in profitable niche products leveraged from this service business.

Corporate and Other: We are continuing our focus on reducing working capital and maximizing cash generation. In addition, we will continue to focus on tax efficiency; however, incremental income is more likely to be earned in locales with higher incremental rates. We believe our global effective tax rate will approximate 14%, but will vary based on the locales in which incremental income is actually earned. We increased our quarterly dividend by 4% in 2009 to $0.125 per share. Under our existing share repurchase program, we have the ability to periodically repurchase shares in 2009. In addition, we remain committed to evaluating the merits of any opportunities that may arise for acquisitions that complement our business footprint.

Additional information regarding our products, markets and financial performance is provided at our web site, www.albemarle.com. Our web site is not a part of this document nor is it incorporated herein by reference.

 

15


Table of Contents

Results of Operations

The following data and discussion provides an analysis of certain significant factors affecting our results of operations during the periods included in the accompanying consolidated statements of income.

First Quarter 2009 Compared with First Quarter 2008

 

Selected Financial Data (Unaudited)

      
     Three Months Ended
March 31,
    Percentage
Change
 
     2009     2008     2009 vs. 2008  
     (In millions, except percentages and
per share amounts)
 

NET SALES

   $ 486.6     $ 668.2     (27 )%

Cost of goods sold

     396.1       500.8     (21 )%
                      

GROSS PROFIT

     90.5       167.4     (46 )%

GROSS PROFIT MARGIN

     18.6 %     25.1 %  

Selling, general and administrative expenses

     45.4       63.5     (29 )%

Research and development expenses

     16.2       16.8     (4 )%

Restructuring charges

     —         3.3     *  
                      

OPERATING PROFIT

     28.9       83.8     (66 )%

OPERATING PROFIT MARGIN

     5.9 %     12.5 %  

Interest and financing expenses

     (6.3 )     (10.2 )   (38 )%

Other (expenses) income, net

     (1.1 )     2.8     *  
                      

INCOME BEFORE INCOME TAX EXPENSE AND EQUITY IN NET INCOME OF UNCONSOLIDATED INVESTMENTS

     21.5       76.4     (72 )%

Income tax expense

     0.5       16.6     (97 )%

Effective tax rate

     2.4 %     21.8 %  
                      

INCOME BEFORE EQUITY IN NET INCOME OF UNCONSOLIDATED INVESTMENTS

     21.0       59.8     (65 )%

Equity in net income of unconsolidated investments (net of tax)

     5.9       7.1     (17 )%
                      

NET INCOME

     26.9       66.9     (60 )%

Net income attributable to noncontrolling interests

     (1.5 )     (3.6 )   (58 )%
                      

NET INCOME ATTRIBUTABLE TO ALBEMARLE CORPORATION

   $ 25.4     $ 63.3     (60 )%
                      

PERCENTAGE OF NET SALES

     5.2 %     9.5 %  
                      

Basic earnings per share

   $ 0.28     $ 0.68     (59 )%
                      

Diluted earnings per share

   $ 0.28     $ 0.67     (58 )%
                      
 
  * Calculation is not meaningful.

Net Sales

For the three-month period ended March 31, 2009, we recorded net sales of $486.6 million, a 27% decrease compared to net sales of $668.2 million for the three-month period ended March 31, 2008. This decrease was due primarily to a decline in volumes in all segments. Volumes had a negative impact on sales of 27%, foreign currency changes caused a 3% decrease and price and product mix had a positive impact on sales of 3% compared to the same period last year.

Polymer Additives net sales decreased $121.4 million, or 50%, for the three-month period ended March 31, 2009 compared to the same period in 2008 as a result of a decrease in volumes. Foreign currency also contributed to the decline, but this nominal impact was offset by similar improvements in price and product mix. Catalysts net sales decreased $33.5 million, or 12%, compared to the same period last year due mainly to a decrease in volumes contributing 11% and foreign currency impacts of 3%. These declines were partially offset by price and product mix improvements contributing 2% despite unfavorable metals impacts on HPC refinery catalysts net sales. Fine Chemicals net sales decreased $26.7 million, or 18%, compared to the same period last year primarily due to volumes contributing 22% of the decrease, foreign currency impacts of 2%, and was partially offset by improvements in price and product mix contributing 6%. For a detailed discussion of revenues and segment income before taxes for each segment see “Segment Information Overview” below.

 

16


Table of Contents

Gross Profit

For the three-month period ended March 31, 2009, our gross profit decreased $76.9 million, or 46%, to $90.5 million from the corresponding 2008 period due mainly to volume declines, unfavorable production rate impacts on cost in our bromine franchise and high cost metals impacts on HPC refinery catalysts. These factors contributed to our decline in gross profit margin for the three-month period ended March 31, 2009 to 18.6% from 25.1% for the corresponding period in 2008.

Selling, General and Administrative Expenses

For the three-month period ended March 31, 2009, our selling, general and administrative, or SG&A, expenses decreased $18.1 million, or 29%, from the three-month period ended March 31, 2008. This decrease was primarily due to adjustments of $7.0 million associated with the reversal of certain long-term employee benefit accruals and a reduction in salaries and benefits as a result of our recent cost saving actions. As a percentage of net sales, SG&A expenses were 9.3% for the three-month period ended March 31, 2009 compared to 9.5% for the corresponding period in 2008.

Research and Development Expenses

For the three-month period ended March 31, 2009, our research and development expenses decreased $0.6 million, or 4%, from the three-month period ended March 31, 2008. As a percentage of net sales, research and development expenses were 3.3% for the three-month period ended March 31, 2009 compared to 2.5% for the corresponding period in 2008.

Restructuring Charges

The three-month period ended March 31, 2008 includes charges amounting to $3.3 million ($2.1 million after income taxes) that relate to severance in conjunction with personnel reductions at the Company’s former Richmond, Virginia headquarters and Singapore sales office.

Interest and Financing Expenses

Interest and financing expenses for the three-month period ended March 31, 2009 decreased $3.9 million to $6.3 million from the corresponding 2008 period due to lower average interest rates.

Other (Expenses) Income, Net

Other (expenses) income, net for the three-month period ended March 31, 2009 increased $3.9 million from the corresponding 2008 period due primarily to an increase in foreign currency exchange losses and a decrease in interest income as a result of lower average interest rates.

Income Tax Expense

Our effective tax rate fluctuates based on, among other factors, where income is earned and the level of income relative to available tax credits. For the three-month period ended March 31, 2009, our effective income tax rate was 2.4% as compared to 21.8% for the three-month period ended March 31, 2008. The effective income tax rate for the three-month period ended March 31, 2009, is impacted by various non-recurring items totaling a net $2.5 million benefit, resulting from adjustments related to prior periods. Of this net benefit, the significant items were a $1.2 million increase in a valuation allowance for losses at our Brazilian entity and a net benefit of $2.7 million related to unrecognized tax benefits. Based on our current level and location of income, we anticipate that our effective tax rate for 2009 will approximate 14%.

 

17


Table of Contents

The significant differences between the U.S. federal statutory income tax rate on pretax income and the effective income tax rate for the three-month periods ended March 31, 2009 and 2008 are as follows:

 

     % of Income Before Income Taxes  
     Three Months Ended
March 31,
 
     2009     2008  

Federal statutory rate

   35.0 %   35.0 %

State taxes, net of federal tax benefit

   0.2     0.5  

Impact of foreign operations, net

   (19.4 )   (13.1 )

Increase in valuation allowance

   0.2     —    

Depletion

   (1.7 )   (1.2 )

Effect of net income attributable to noncontrolling interests

   (0.1 )   (0.5 )

Revaluation of unrecognized tax benefits/reserve requirements

   0.6     1.0  

Other items, net

   (0.8 )   0.1  
            

Effective income tax rate excluding non-recurring items

   14.0 %   21.8 %

Non-recurring items

   (11.6 )   —    
            

Effective income tax rate

   2.4 %   21.8 %
            

Equity in Net Income of Unconsolidated Investments

Equity in net income of unconsolidated investments was $5.9 million for the three-month period ended March 31, 2009 compared to $7.1 million in the same period last year. This decrease of $1.2 million is due primarily to lower equity earnings from our Magnifin joint venture in our Polymer Additives segment due to decreased volumes as a result of weakness in the automotive sector, partially offset by net increased equity earnings from our various Catalysts segment joint ventures.

Net Income Attributable to Noncontrolling Interests

For the three-month period ended March 31, 2009, net income attributable to noncontrolling interests was $1.5 million compared to $3.6 million in the same period last year. This decrease of $2.1 million is due primarily to lower earnings of Stannica LLC as a result of a decline in volume due to the weak construction sector. In addition, earnings of Jordan Bromine Company Limited were lower as a result of a decline in bromine volumes.

Net Income Attributable to Albemarle Corporation

Net income attributable to Albemarle Corporation decreased to $25.4 million in the three-month period ended March 31, 2009 from $63.3 million in the three-month period ended March 31, 2008 primarily due to volume declines and unfavorable costs in our bromine franchise and high cost metals impacts on HPC refinery catalysts.

Segment Information Overview. We have identified three reportable segments as required by SFAS No. 131, “Disclosures about Segments of an Enterprise and Related Information.” Our Polymer Additives segment is comprised of the flame retardants and stabilizers and curatives product areas. Our Catalysts segment is comprised of the refinery catalysts and polyolefin catalysts product areas. Our Fine Chemicals segment is comprised of the performance chemicals and fine chemistry services and intermediates product areas. Segment income represents operating profit (adjusted for significant non-recurring items) and equity in net income of unconsolidated investments and is reduced by net income attributable to noncontrolling interests. Segment data includes intersegment transfers of raw materials at cost, foreign exchange transaction gains and losses and allocations for certain corporate costs.

 

18


Table of Contents
     Three Months Ended March 31,     Percentage
Change
 
     2009     % of
net sales
    2008     % of
net sales
    2009 vs 2008  
     (In millions, except percentages)  

Net sales:

          

Polymer Additives

   $ 123.2     25.3 %   $ 244.6     36.6 %   (50 )%

Catalysts

     242.6     49.9 %     276.1     41.3 %   (12 )%

Fine Chemicals

     120.8     24.8 %     147.5     22.1 %   (18 )%
                              

Total net sales

   $ 486.6     100.0 %   $ 668.2     100.0 %   (27 )%
                              

Segment operating profit (loss):

          

Polymer Additives

   $ (11.5 )   *     $ 30.3     12.4 %   (138 )%

Catalysts

     29.8     12.3 %     46.1     16.7 %   (35 )%

Fine Chemicals

     10.2     8.4 %     23.5     15.9 %   (57 )%
                      

Subtotal

   $ 28.5       $ 99.9       (71 )%
                      

Equity in net income (loss) of unconsolidated investments:

          

Polymer Additives

   $ —         $ 1.5       (100 )%

Catalysts

     5.9         5.6       5 %

Fine Chemicals

     —           —         —   %

Corporate & other

     —           —         —   %
                      

Total equity in net income of unconsolidated investments

   $ 5.9       $ 7.1       (17 )%
                      

Net (income) loss attributable to noncontrolling interests:

          

Polymer Additives

   $ (0.2 )     $ (2.0 )     (90 )%

Catalysts

     —           —         —   %

Fine Chemicals

     (1.5 )       (2.0 )     (25 )%

Corporate & other

     0.2         0.4       *  
                      

Total net income attributable to noncontrolling interests

   $ (1.5 )     $ (3.6 )     (58 )%
                      

Segment income (loss):

          

Polymer Additives

   $ (11.7 )   *     $ 29.8     12.2 %   (139 )%

Catalysts

     35.7     14.7 %     51.7     18.7 %   (31 )%

Fine Chemicals

     8.7     7.2 %     21.5     14.6 %   (60 )%
                      

Total segment income

     32.7         103.0       (68 )%

Corporate & other

     0.6         (12.4 )     (105 )%

Restructuring charges

     —           (3.3 )     *  

Interest and financing expenses

     (6.3 )       (10.2 )     (38 )%

Other (expenses) income, net

     (1.1 )       2.8       *  

Income tax expense

     (0.5 )       (16.6 )     (97 )%
                      

Net income attributable to Albemarle Corporation

   $ 25.4       $ 63.3       (60 )%
                      

 

* Calculation is not meaningful.

 

19


Table of Contents

Polymer Additives

Polymer Additives segment net sales for the three-month period ended March 31, 2009 were $123.2 million, down $121.4 million, or 50%, versus the three-month period ended March 31, 2008. This decline is a result of a decrease in volumes primarily in our flame retardants portfolio as a result of the continued weakness in consumer electronics, automotive and construction sectors. Net sales also declined in our stabilizers and curatives product lines primarily due to reduced volumes in our antioxidants. Segment income declined 139%, or $41.5 million, to a loss of $11.7 million due mainly to lower sales volumes as well as lower production volumes which contributed to unfavorable fixed cost absorption for the three-month period ended March 31, 2009 as compared to the three-month period ended March 31, 2008.

Catalysts

Catalysts segment net sales for the three-month period ended March 31, 2009 were $242.6 million, a decrease of $33.5 million, or 12%, versus the three-month period ended March 31, 2008. This decrease was due primarily to unfavorable metals impacts on HPC refinery catalysts revenues, foreign currency exchange rates and lower FCC refinery catalysts volumes, and is partially offset by improved pricing in FCC refinery catalysts and Polyolefin catalysts. Segment income decreased 31%, or $16.0 million, to $35.7 million for the three-month period ended March 31, 2009 compared to the same period in 2008, due mainly to unfavorable metals impacts on HPC refinery catalysts.

Fine Chemicals

Fine Chemicals segment net sales for the three-month period ended March 31, 2009 were $120.8 million, a decrease of $26.7 million, or 18%, versus the three-month period ended March 31, 2008. Segment income for the three-month period ended March 31, 2009 was $8.7 million, down $12.8 million, or 60% from the three-month period ended March 31, 2008. These declines were due mainly to reduced sales and production volumes in our bromine franchise. We tightly managed inventory during the first quarter of 2009 and held operating rates low on our bromine manufacturing assets, contributing to unfavorable profit effects from lower fixed cost absorption.

Corporate and other

For the three-month period ended March 31, 2009, our Corporate and other expenses decreased $13.0 million, or 105%, to income of $0.6 million from the three-month period ended March 31, 2008. This decrease was primarily due to adjustments of $7.8 million associated with the reversal of certain long-term employee benefit accruals. This adjustment is primarily included in “selling, general and administrative expenses” in our consolidated statements of income.

Financial Condition and Liquidity

Overview

The principal uses of cash in our business generally have been investment in our assets, funding working capital and repayment of debt. In 2008, we made a $25.0 million voluntary contribution to our U.S. defined benefit pension plans. Historically, cash to fund the needs of our business has been principally provided by cash from operations, debt financing and equity issuances.

We are continuing our program to improve working capital efficiency and working capital metrics particularly in the areas of accounts receivable and inventory. We expect the combination of our current cash balances and availability under our March 2007 credit agreement, which is discussed below, to remain sufficient to fund working capital requirements for the foreseeable future.

Cash Flow

Our cash balance decreased by $69.4 million to $183.9 million at March 31, 2009 from $253.3 million at December 31, 2008. For the three-month period ended March 31, 2009, we used cash in operating activities of $4.1 million compared to $18.8 million provided by operating activities in the three-month period ended March 31, 2008. This decrease of $22.9 million is primarily due to a decrease in profitability, partially offset by improved working capital management compared to the first quarter of 2008. Cash on hand funded capital expenditures for plant, machinery and equipment of $33.1 million, net repayments of long-term debt of $13.7 million and dividends to shareholders of $11.0 million.

Net current assets decreased $61.9 million to $678.7 million at March 31, 2009 from $740.6 million at December 31, 2008. The decrease in net current assets was due primarily to a decrease in cash and inventory, partially offset by a decrease in accounts payable and accrued expenses.

 

20


Table of Contents

Capital expenditures for the three-month period ended March 31, 2009 of $33.1 million were used for plant, machinery and equipment improvements. We expect our capital expenditures to be approximately $90 million in 2009 mainly due to increases in plant, machinery and equipment in our Catalysts and Fine Chemicals segments. However, we are closely monitoring our willingness to fund our capital plan in light of the global economic situation and our cash generation as the year progresses. We anticipate that future capital spending will be financed primarily with cash flow provided from operations with additional cash needed, if any, provided by borrowings including amounts available under our March 2007 credit agreement. The amount and timing of any additional borrowings will depend on our specific cash requirements.

Long-Term Debt

We currently have outstanding $325.0 million of 5.10% senior notes due in 2015. The senior notes are senior unsecured obligations and rank equally with all of our other senior unsecured indebtedness outstanding from time to time. The senior notes will be effectively subordinated to any of our future secured indebtedness and to the existing and future indebtedness of our subsidiaries. We may redeem the senior notes before their maturity, in whole at any time or in part from time to time, at a redemption price equal to the greater of (1) 100% of the principal amount of the senior notes to be redeemed or (2) the sum of the present values of the remaining scheduled payments of principal and interest thereon (exclusive of interest accrued to the date of redemption) discounted to the redemption date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate (as defined in the indenture governing the senior notes) plus 15 basis points, plus, in each case, accrued interest thereon to the date of redemption.

The principal amount of the senior notes becomes immediately due and payable upon the occurrence of certain bankruptcy or insolvency events involving us or certain of our subsidiaries and may be declared immediately due and payable by the trustee or the holders of not less than 25% of the senior notes upon the occurrence of an event of default. Events of default include, among other things: failure to pay principal or interest at required times; failure to perform or remedy a breach of covenants within prescribed periods; an event of default on any of our other indebtedness or certain indebtedness of our subsidiaries of $40.0 million or more that is caused by a failure to make a payment when due or that results in the acceleration of that indebtedness before its maturity; and certain bankruptcy or insolvency events involving us or certain of our subsidiaries. We believe that as of March 31, 2009, we were, and currently are, in compliance with all of the covenants of the indenture governing the senior notes.

For additional funding and liquidity purposes, we currently maintain a $675.0 million five-year unsecured revolving senior credit facility, which we refer to as the March 2007 credit agreement. The March 2007 credit agreement provides for an additional $200.0 million in credit, if needed, upon additional loan commitments by our existing and/or additional lenders. The total spreads and fees can range from 0.32% to 0.675% over the London inter-bank offered rate, or LIBOR, applicable to the currency of denomination of the borrowing and are based upon our credit rating from one of the major credit rating agencies. There were aggregate borrowings outstanding under the March 2007 credit agreement of $495.0 million at March 31, 2009. Borrowings under the March 2007 credit agreement bear interest at variable rates, which was a weighted average of 1.01% during the three-month period ended March 31, 2009.

In March 2008, we exercised an option under the March 2007 credit agreement to extend the maturity date from March 2012 to March 2013. Lenders representing 87.4% of the commitments, or $590 million out of $675 million, approved the extension. No other changes to the agreement were part of the extension, and no fees, other than attorney fees, were paid. As a result of the extension, $85 million and $590 million in commitments now have a maturity/expiration date of March 2012 and March 2013, respectively.

Borrowings under our March 2007 credit agreement are conditioned upon compliance with the following covenants: (a) consolidated funded debt, as defined in the March 2007 credit agreement, must be less than or equal to 3.50 times consolidated EBITDA, as defined in the March 2007 credit agreement, as of the end of any fiscal quarter; (b) consolidated tangible domestic assets, as defined in the March 2007 credit agreement, must be greater than or equal to $750.0 million for us to make investments in entities and enterprises that are organized outside the U.S.; and (c) with the exception of liens specified in our March 2007 credit agreement, liens may not attach to assets when the aggregate amount of all indebtedness secured by such liens plus unsecured indebtedness, other than indebtedness incurred by our subsidiaries under the March 2007 credit agreement would exceed 20% of consolidated net worth, as defined in the March 2007 credit agreement. We believe that as of March 31, 2009, we were, and currently are, in compliance with all of the debt covenants under the March 2007 credit agreement.

The non-current portion of our long-term debt amounted to $891.9 million at March 31, 2009, compared to $906.1 million at December 31, 2008. In addition, at March 31, 2009, we had additional capacity to borrow $174.9 million under our March 2007 credit agreement and $155.5 million under other existing lines of credit.

 

21


Table of Contents

Off-Balance Sheet Arrangements

In the normal course of business with customers, vendors and others, we have entered into off-balance sheet arrangements, including bank guarantees and letters of credit which totaled approximately $36.8 million at March 31, 2009. None of these off-balance sheet arrangements either has, or is likely to have, a material effect on our current or future financial condition, results of operations, liquidity or capital resources.

Other Obligations

The following table summarizes our contractual obligations for plant construction, purchases of equipment and various take or pay and throughput agreements (in thousands):

 

    2Q
2009
  3Q
2009
  4Q
2009
  Sub-total
2009
  2010   2011   2012   2013   2014   Thereafter

Long-term debt obligations

  $ 16,060   $ 1,467   $ 3,115   $ 20,642   $ 9,695   $ 5,240   $ 5,464   $ 504,829   $ 6,013   $ 353,647

Capital lease obligation

    1,652     —       1,700     3,352     3,546     3,750     1,956     —       —       —  

Expected interest payments on long-term debt obligations*

    7,346     7,281     7,135     21,762     28,991     32,960     32,356     22,631     19,533     8,716

Operating lease obligations (rental)

    2,408     2,408     2,408     7,224     7,441     5,284     3,948     2,706     2,457     17,202

Take or pay / throughput agreements**

    14,327     14,327     14,326     42,980     17,249     10,839     5,025     4,963     4,657     7,862

Letters of credit and guarantees

    10,884     3,131     1,726     15,741     10,493     1,397     720     373     —       8,109

Capital projects

    23,770     4,886     1,661     30,317     3,440     986     —       —       —       —  

Facility divestiture obligation

    1,971     1,971     1,971     5,913     5,256     —       —       —       —       —  

Additional investment commitment payments

    —       —       45     45     —       —       —       —       —       —  
                                                           

Total

  $ 78,418   $ 35,471   $ 34,087   $ 147,976   $ 86,111   $ 60,456   $ 49,469   $ 535,502   $ 32,660   $ 395,536
                                                           

 

* These amounts are based on a weighted-average interest rate of 1.4% for the March 2007 credit agreement, 5.1% for the senior notes, and 5.1% for our remaining long-term debt obligations and capital lease for 2009. The weighted average rate for years 2010 and thereafter is 2.3% for the March 2007 credit agreement, 5.1% for the senior notes, and 4.6% for our remaining long-term debt obligations and capital lease.
** These amounts primarily relate to contracts entered into with certain third party vendors in the normal course of business to secure raw materials for our production processes. In order to secure materials, sometimes for long durations, these contracts mandate a minimum amount of product to be purchased at predetermined rates over a set timeframe.

Amounts in the table above exclude required employer pension contributions. We have determined that the total expected 2009 contributions to our domestic nonqualified and foreign qualified and nonqualified pension plans should approximate $9.0 million. We may choose to make additional pension contributions above this amount. We have made $1.5 million in contributions to our qualified and nonqualified pension plans during the three-month period ended March 31, 2009.

We are subject to federal, state, local, and foreign requirements regulating the handling, manufacture and use of materials (some of which may be classified as hazardous or toxic by one or more regulatory agencies), the discharge of materials into the environment and the protection of the environment. To our knowledge, we are currently complying and expect to continue to comply in all material respects with applicable environmental laws, regulations, statutes and ordinances. Compliance with existing federal, state, local, and foreign environmental protection laws is not expected to have a material effect on earnings or our competitive position, but the costs associated with increased legal or regulatory requirements could have an adverse effect on our results.

Among other environmental requirements, we are subject to the federal Superfund law, and similar state laws, under which we may be designated as a potentially responsible party, or PRP, and may be liable for a share of the costs associated with cleaning up various hazardous waste sites. Management believes that in most cases, our participation is de minimis. Further, almost all such sites represent environmental issues that are quite mature and have been investigated, studied and in many cases settled. In de minimis situations, our policy generally is to negotiate a consent decree and to pay any apportioned settlement, enabling us to be effectively relieved of any further liability as a PRP, except for remote contingencies. In other than de minimis PRP matters, our records indicate that unresolved PRP exposures should be immaterial. We accrue and expense our proportionate share of PRP costs. Because management has been actively involved in evaluating environmental matters, we are able to conclude that the outstanding environmental liabilities for unresolved PRP sites should not be material to operations.

 

22


Table of Contents

Liquidity Outlook

We anticipate that cash provided from operating activities in the future and borrowings under our March 2007 credit agreement will be sufficient to pay our operating expenses, satisfy debt service obligations, fund capital expenditures and pension contributions, and make dividend payments for the foreseeable future. In addition, as we have historically done, we will continue to evaluate the merits of any opportunities that may arise for acquisitions of businesses or assets, which may require additional liquidity.

While we maintain business relationships with a diverse group of financial institutions, their continued viability is not certain and could lead them not to honor their contractual credit commitments or to renew their extensions of credit or provide new sources of credit. Recently, the capital markets have become increasingly volatile as a result of adverse conditions that have caused the consolidation, failure and near failure of a number of large financial services companies. If the capital markets continue to experience volatility and the availability of funds remains limited, we may incur increased costs associated with borrowings. In addition, it is possible that our ability to access the capital markets may be limited by these or other factors at a time when we would like, or need, to do so, which could have an impact on our ability to finance our businesses or react to changing economic and business conditions. While we believe that recent governmental and regulatory actions reduce the risk of a further deterioration or systemic contraction of capital markets, there can be no certainty that our liquidity will not be negatively impacted. In addition, our cash flows from operations may be adversely affected by adverse consequences to our customers and the markets in which we compete as a result of the current financial, economic, and capital market conditions and uncertainty.

At March 31, 2009, we had total additional capacity to borrow in excess of $300 million under our March 2007 credit agreement and other existing lines of credit. With generally strong cash generative businesses and no significant debt maturities before 2013, we believe we have a solid liquidity position given the current financial market situation.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

There have been no significant changes in our interest rate risk, foreign currency exchange rate exposure, marketable securities price risk, or raw material price risk from the information we provided in the Annual Report on Form 10-K for the year ended December 31, 2008 except as noted below.

We had outstanding variable interest rate borrowings at March 31, 2009 of $533.9 million, bearing an average interest rate of 1.10%. A hypothetical 10% change (approximately 11 basis points) in the interest rate applicable to these borrowings would change our annualized interest expense by approximately $0.6 million as of March 31, 2009. We may enter into interest rate swaps, collars or similar instruments with the objective of reducing interest rate volatility relating to our borrowing costs.

In 2004, we entered into treasury lock agreements, or T-locks, with a notional value of $275.0 million, to fix the yield on the U.S. Treasury security used to set the yield for approximately 85% of our January 2005 public offering of senior notes. The T-locks fixed the yield on the U.S. Treasury security at approximately 4.25%. The value of the T-locks resulted from the difference between (1) the yield-to-maturity of the 10-year U.S. Treasury security that had the maturity date most comparable to the maturity date of the notes issued and (2) the fixed rate of approximately 4.25%. The cumulative loss effect of the T-lock agreements was $2.2 million and is being amortized over the life of the notes as an adjustment to the notes interest expense. At March 31, 2009, there were losses of approximately $1.3 million ($0.8 million after income taxes) in accumulated other comprehensive loss that remain to be expensed.

In addition, certain of our operations use natural gas as a source of energy which can expose our business to market risk when the price of natural gas changes suddenly. In an attempt to mitigate the impact and volatility of price swings in the natural gas market, we purchase natural gas contracts, when appropriate, for a portion of our 12-month rolling forecast for North American natural gas requirements.

Our natural gas hedge transactions are executed with major financial institutions. Such derivatives are held to secure natural gas at fixed prices and not for trading. Our natural gas hedge contracts qualify as cash flow hedges and are marked to market. The unrealized gains and/or losses on these contracts are deferred and accounted for in accumulated other comprehensive loss to the extent that the unrealized gains and losses are offset by the forecasted transaction. At March 31, 2009, there were no natural gas hedge contracts outstanding and none were purchased in the three-month period ended March 31, 2009. Additionally, any unrealized gains and/or losses on the derivative instrument that are not offset by the forecasted transaction are recorded in earnings as appropriate, but do not have a significant impact on results of operations.

 

23


Table of Contents
Item 4. Controls and Procedures.

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, or the Exchange Act), as of the end of the period covered by this report. Based on this evaluation, our principal executive officer and principal financial officer concluded that, as of end of the period covered by this report, our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act, is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

No change in our internal control over financial reporting (as such term is defined in Exchange Act Rule 13a-15(f)) occurred during the fiscal quarter ended March 31, 2009 that materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

 

Item 1. Legal Proceedings.

On July 3, 2006, we received a Notice of Violation, or NOV, from the U.S. Environmental Protection Agency Region 4, or EPA, regarding the implementation of the Pharmaceutical Maximum Achievable Control Technology standards at our plant in Orangeburg, SC. The alleged violations include (i) the applicability of the specific regulations to certain intermediates manufactured at the plant, (ii) failure to comply with certain reporting requirements, (iii) improper evaluation and testing to properly implement the regulations and (iv) the sufficiency of the leak detection and repair program at the plant. We are currently engaged in discussions with the EPA seeking to resolve these allegations, but no assurances can be given that we will be able to reach a resolution that is acceptable to both parties. Any settlement or finding adverse to us could result in the payment by us of fines, penalties, capital expenditures, or some combination thereof. At this time, it is not possible to predict with any certainty the outcome of our discussions with the EPA or the financial impact which may result therefrom. However, we do not expect any financial impact to have a material adverse effect on the results of operations or the financial position of the Company.

In addition, we are involved from time to time in legal proceedings of types regarded as common in our businesses, particularly administrative or judicial proceedings seeking remediation under environmental laws, such as Superfund, products liability and premises liability litigation. We maintain a financial accrual for these proceedings that includes defense costs and potential damages, as estimated by our general counsel. We also maintain insurance to mitigate certain of such risks.

 

Item 1A. Risk Factors.

While we attempt to identify, manage and mitigate risks and uncertainties associated with our business to the extent practical under the circumstances, some level of risk and uncertainty will always be present. Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2008 describes some of the risks and uncertainties associated with our business. These risks and uncertainties have the potential to materially affect our results of operations and our financial condition. We do not believe that there have been any material changes to the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2008.

 

24


Table of Contents
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

The following table summarizes our repurchases of equity securities for the three-month period ended March 31, 2009:

 

Period    Total Number
of Shares
Repurchased
   Average Price
Paid Per
share
   Total Number of Shares
Repurchased as Part of

Publicly Announced Plan
or Program *
   Maximum Number of
Shares that May Yet Be
Repurchased Under the
Plans or Programs *

January 1, 2009 to January 31, 2009

   —      —      —      4,400,000

February 1, 2009 to February 28, 2009

   —      —      —      4,400,000

March 1, 2009 to March 31, 2009

   —      —      —      4,400,000
                   

Total

   —      —      —      4,400,000
                   

 

* The stock repurchase plan, which was authorized by our Board of Directors, became effective on October 25, 2000 and included ten million shares. On February 27, 2008 after 98% of the originally authorized repurchase was executed, our Board of Directors approved an increase to five million shares authorized for repurchase under our stock repurchase plan. The stock repurchase plan will expire when we have repurchased all shares authorized for repurchase thereunder, unless the repurchase plan is earlier terminated by action of our Board of Directors or further shares are authorized for repurchase.

 

Item 6. Exhibits.

(a) Exhibits

 

31.1    Certification of Chief Executive Officer pursuant to Rule 13a-14(a)
31.2    Certification of Chief Financial Officer pursuant to Rule 13a-14(a)
32.1    Certification of Chief Executive Officer pursuant to Rule 13a-14(b) and 18 U.S.C. Section 1350
32.2    Certification of Chief Financial Officer pursuant to Rule 13a-14(b) and 18 U.S.C. Section 1350

 

25


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  ALBEMARLE CORPORATION
  (Registrant)
Date: May 8, 2009   By:  

/s/ RICHARD J. DIEMER, JR.

    Richard J. Diemer, Jr.
   

Senior Vice President and Chief Financial Officer

(principal financial and accounting officer)

 

26

Section 302 CEO Certification

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

I, Mark C. Rohr, certify that:

 

  1. I have reviewed this Quarterly Report on Form 10-Q of Albemarle Corporation for the period ended March 31, 2009;

 

  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

  3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

  4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with generally accepted accounting principles;

 

  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

  5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: May 8, 2009

/s/ MARK C. ROHR

Mark C. Rohr
Chairman of the Board, President, and Chief Executive Officer
Section 302 CFO Certification

Exhibit 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

I, Richard J. Diemer, Jr., certify that:

 

  1. I have reviewed this Quarterly Report on Form 10-Q of Albemarle Corporation for the period ended March 31, 2009;

 

  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

  3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

  4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external reporting purposes in accordance with generally accepted accounting principles;

 

  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

  5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 8, 2009

 

/s/ RICHARD J. DIEMER, JR.

Richard J. Diemer, Jr.
Senior Vice President and Chief Financial Officer
Section 906 CEO Certification

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Albemarle Corporation (the “Company”) for the period ended March 31, 2009 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Mark C. Rohr, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

  (1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

  (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ MARK C. ROHR

Mark C. Rohr
Chairman of the Board, President, and Chief Executive Officer
May 8, 2009
Section 906 CFO Certification

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of Albemarle Corporation (the “Company”) for the period ended March 31, 2009 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Richard J. Diemer, Jr., Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

  (1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

  (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ RICHARD J. DIEMER, JR.

Richard J. Diemer, Jr.
Senior Vice President and Chief Financial Officer
May 8, 2009